nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advancing the field of drug delivery
|
Moses, Marsha A |
|
2003 |
4 |
5 |
p. 337-341 5 p. |
artikel |
2 |
Homeobox genes and cancer
|
Abate-Shen, Cory |
|
2003 |
4 |
5 |
p. 329-330 2 p. |
artikel |
3 |
Identification of potential anticancer drug targets through the selection of growth-inhibitory genetic suppressor elements
|
Primiano, Thomas |
|
2003 |
4 |
5 |
p. 415- 1 p. |
artikel |
4 |
Modeling transformation and metastasis in Drosophila
|
Tapon, Nicolas |
|
2003 |
4 |
5 |
p. 333-335 3 p. |
artikel |
5 |
Oct-3/4 is a dose-dependent oncogenic fate determinant
|
Gidekel, Sharon |
|
2003 |
4 |
5 |
p. 361-370 10 p. |
artikel |
6 |
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
|
Chipuk, Jerry E. |
|
2003 |
4 |
5 |
p. 371-381 11 p. |
artikel |
7 |
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
|
Hoffman, Jason A. |
|
2003 |
4 |
5 |
p. 383-391 9 p. |
artikel |
8 |
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
|
Joyce, Johanna A |
|
2003 |
4 |
5 |
p. 393-403 11 p. |
artikel |
9 |
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas
|
Chen, Jindong |
|
2003 |
4 |
5 |
p. 405-413 9 p. |
artikel |
10 |
Tumor vasculature address book
|
Rafii, Shahin |
|
2003 |
4 |
5 |
p. 331-333 3 p. |
artikel |
11 |
Will mTOR inhibitors make it as cancer drugs?
|
Sawyers, Charles L |
|
2003 |
4 |
5 |
p. 343-348 6 p. |
artikel |
12 |
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
|
Liang, Huiling |
|
2003 |
4 |
5 |
p. 349-360 12 p. |
artikel |